Journal: Journal of Nanobiotechnology
Article Title: Endothelial microparticles in high glucose environment: molecular pathways of GDM-associated placental dysfunction and coenzyme Q10-based targeted therapy
doi: 10.1186/s12951-026-04147-1
Figure Lengend Snippet: G-EMPs promote NGFR protein stability by inhibiting its ubiquitination by CYLD. ( A ) Western blot assays revealed that the expression levels of NGFR in HTR8/SVneo cells were affected by G-EMPs (100 particles/cell) after different durations of treatment with 100 µmol/L cycloheximide (CHX). G-EMPs: high glucose (25 mM)-cultured HUVEC-derived EMPs. ( B ) western blot analysis of NGFR expression in response to G-EMP treatment was performed to assess the effects of the proteasome inhibitor MG132 (20 µM) and the autophagy inhibitor CQ (45 µM). P21 serves as a positive control for proteasome regulation, whereas LC3B is a marker for autophagy. ( C ) Co-IP analysis of NGFR ubiquitination in HTR8/SVneo cells transfected with the Ub-HA and NGFR-Flag plasmids was performed to assess the effects of C-EMPs and G-EMPs treatment. ( D ) Prediction of deubiquitinating enzymes (DUBs) for NGFR in UniProt ( www.uniprot.orgt ). (DSI: deubiquitinases). ( E ) western blot analysis demonstrating the effects of C-EMPs and G-EMPs on NGFR protein expression levels. ( F ) Expression levels of NGFR in placentas from wild-type mice and GDM mice, as well as in placentas from normal pregnancies and GDM patients. ( G ) Assessment of CYLD and NGFR expression in HTR8/SVneo cells following knockdown with si-CYLD or overexpression via the CYLD plasmid. ( H ) western blot analysis was performed to detect the protein levels of CYLD, NGFR, p-ERK, ERK, N-cadherin, and E-cadherin in HTR8/SVneo cells treated with G-EMPs and subjected to CYLD knockdown using si-CYLD. ( I ) Histogram showing the migration area of HTR8/SVneo cells under various treatment conditions. ( J ) Histogram depicting the number of invading HTR8/SVneo cells under different treatment conditions. ( K , L ) western blot analysis demonstrating the co-IP results of NGFR-Flag and CYLD-His. ( M , N ) Co-IP analysis assessing the ubiquitination status of NGFR following CYLD overexpression and si-CYLD knockdown. ( O , P ) A ubiquitination assay demonstrated that CYLD inhibited NGFR K63-linked ubiquitination in HTR8/SVneo cells but had little effect on NGFR K48-linked ubiquitination. ( Q ) Representative immunoblots showing the interaction between NGFR and truncated CYLD, as indicated by co-IP assays. The CYLD protein is composed of two CAP-Gly domains (CAP), a phosphorylation ( P ) region, a GAP domain and a ubiquitin-specific protease (USP) catalytic domain. ( R ) Representative immunoblots showing the interaction between CYLD and truncated NGFR. NGFR consists of extracellularly cysteine-rich domains (CRDs), a serine/threonine-rich (S/T-rich) stalk, a chopper and a death domain. The data were analyzed using one-way ANOVA with Tukey’s post-hoc test. Data are presented as mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001
Article Snippet: The human trophoblast cell lines HTR8/SVneo (CRL-3271, ATCC, USA) and JEG-3 (HTB-36, ATCC, USA) were purchased from the American Type Culture Collection.
Techniques: Ubiquitin Proteomics, Western Blot, Expressing, Cell Culture, Derivative Assay, Positive Control, Marker, Co-Immunoprecipitation Assay, Transfection, Knockdown, Over Expression, Plasmid Preparation, Migration, Phospho-proteomics